Literature DB >> 18314482

The identification of microRNAs in a genomically unstable region of human chromosome 8q24.

Konrad Huppi1, Natalia Volfovsky, Timothy Runfola, Tamara L Jones, Mark Mackiewicz, Scott E Martin, J Frederic Mushinski, Robert Stephens, Natasha J Caplen.   

Abstract

The PVT1 locus is identified as a cluster of T(2;8) and T(8;22) "variant" MYC-activating chromosomal translocation breakpoints extending 400 kb downstream of MYC in a subset (approximately 20%) of Burkitt's lymphoma (vBL). Recent reports that microRNAs (miRNA) may be associated with fragile sites and cancer-associated genomic regions prompted us to investigate whether the PVT1 region on chromosome 8q24 may contain miRNAs. Computational analysis of the genomic sequence covering the PVT1 locus and experimental verification identified seven miRNAs. One miRNA, hsa-miR-1204, resides within a previously described PVT1 exon (1b) that is often fused to the immunoglobulin light chain constant region in vBLs and is present in high copy number in MYC/PVT1-amplified tumors. Like its human counterpart, mouse mmu-miR-1204 represents the closest miRNA to Myc (~50 kb) and is found only 1 to 2 kb downstream of a cluster of retroviral integration sites. Another miRNA, mmu-miR-1206, is close to a cluster of variant translocation breakpoints associated with mouse plasmacytoma and exon 1 of mouse Pvt1. Virtually all the miRNA precursor transcripts are expressed at higher levels in late-stage B cells (including plasmacytoma and vBL cell lines) compared with immature B cells, suggesting possible roles in lymphoid development and/or lymphoma. In addition, lentiviral vector-mediated overexpression of the miR-1204 precursor (human and mouse) in a mouse pre-B-cell line increased expression of Myc. High levels of expression of the hsa-miR-1204 precursor is also seen in several epithelial cancer cell lines with MYC/PVT1 coamplification, suggesting a potentially broad role for these miRNAs in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314482     DOI: 10.1158/1541-7786.MCR-07-0105

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  87 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 3.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

Review 4.  Genomic instability and mouse microRNAs.

Authors:  Konrad Huppi; Jason Pitt; Brady Wahlberg; Natasha J Caplen
Journal:  Toxicol Mech Methods       Date:  2011-05       Impact factor: 2.987

5.  Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Authors:  Brian D Juran; Gideon M Hirschfield; Pietro Invernizzi; Elizabeth J Atkinson; Yafang Li; Gang Xie; Roman Kosoy; Michael Ransom; Ye Sun; Ilaria Bianchi; Erik M Schlicht; Ana Lleo; Catalina Coltescu; Francesca Bernuzzi; Mauro Podda; Craig Lammert; Russell Shigeta; Landon L Chan; Tobias Balschun; Maurizio Marconi; Daniele Cusi; E Jenny Heathcote; Andrew L Mason; Robert P Myers; Piotr Milkiewicz; Joseph A Odin; Velimir A Luketic; Bruce R Bacon; Henry C Bodenheimer; Valentina Liakina; Catherine Vincent; Cynthia Levy; Andre Franke; Peter K Gregersen; Fabrizio Bossa; M Eric Gershwin; Mariza deAndrade; Christopher I Amos; Konstantinos N Lazaridis; Michael F Seldin; Katherine A Siminovitch
Journal:  Hum Mol Genet       Date:  2012-08-29       Impact factor: 6.150

6.  miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.

Authors:  Dibash K Das; Michelle Naidoo; Adeodat Ilboudo; Jong Y Park; Thahmina Ali; Konstantinos Krampis; Brian D Robinson; Joseph R Osborne; Olorunseun O Ogunwobi
Journal:  Exp Cell Res       Date:  2016-09-29       Impact factor: 3.905

7.  Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Authors:  Sungshim Lani Park; Shen-Chih Chang; Lin Cai; Carlos Cordon-Cardo; Bao-Guo Ding; Sander Greenland; Shehnaz K Hussain; Qingwu Jiang; Simin Liu; Ming-Lan Lu; Jenny T Mao; Hal Morgenstern; Li-Na Mu; Leslie J Ng; Allan Pantuck; Jianyu Rao; Victor E Reuter; Donald P Tashkin; Nai-Chieh Y You; Can-Qing Yu; Shun-Zhang Yu; Jin-Kou Zhao; Arie Belldegrun; Zuo-Feng Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.

Authors:  Meng Cui; Yu Chang; Qi-Gen Fang; Wei Du; Jun-Fu Wu; Ji-Heng Wang; Shan-Ting Liu; Su-Xia Luo
Journal:  Pathol Oncol Res       Date:  2018-08-23       Impact factor: 3.201

9.  Genome profiling of ERBB2-amplified breast cancers.

Authors:  Fabrice Sircoulomb; Ismahane Bekhouche; Pascal Finetti; José Adélaïde; Azza Ben Hamida; Julien Bonansea; Stéphane Raynaud; Charlène Innocenti; Emmanuelle Charafe-Jauffret; Carole Tarpin; Farhat Ben Ayed; Patrice Viens; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

10.  High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Authors:  Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain Bernheim
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.